Differential Effects of Dietary Supplementation with Fish Oil or Soy Lecithin on Human Platelet Adhesion

Summary

To investigate the possible regulating role of ω-6 and of ω-3 fatty acids on platelet adhesiveness, we randomised 60 volunteers into three groups to take 20 ml (equivalent to 0.3 g ω-6, 3.6 g ω-3; ω-6/ω-3 ratio 0.1) per day of a fish oil supplement, or to take 25 g (equivalent to 1.5 g ω-6, 0.5 g ω-3; ω-6/ω-3 ratio 3) per day of a soy lecithin supplement, or to continue on their usual diet without any supplement (control group) for a period of 15 days. Platelet adhesion on fibrinogen-coated 96-well microtitre plates was evaluated in the resting condition and after stimulation with 2 ωM ADP or 0.02 U/ml thrombin. Compared to the values before the experimental period, the fish oil group showed a significant reduction in stimulated adhesion (with ADP: from 18.8% to 15.6%, p <0.01; with thrombin: from 24.4% to 20.8%, p <0.005), whereas no difference was noted in the resting condition (from 3.6% to 3.5%, NS). In the soy lecithin group, platelet adhesion was increased in all test conditions (with ADP: from 18.7% to 23.2%, p <0.001; with thrombin: from 24.0% to 29.9%, p <0.001; resting: from 3.5% to 6.6%, p <0.001). No significant changes were observed in the control group. A good correlation was found between platelet adhesion data and the changes in the platelet fatty acid ω-6/ω-3 ratio caused by the different supplementations. Our results indicate an inhibitory effect of fish oil rich in ω-3 fatty acids on stimulated human platelet adhesiveness and a stimulatory effect of soy lecithin rich in ω-6 fatty acids on resting and stimulated adhesion. They suggest moreover that the ω-6/ω-3 ratio is a determinant of platelet adhesion.

Keywords

Fatty acid - adhesion - platelet - thrombosis

• References

• 1 Budowski P. ω3 fatty acids in health and disease. World Rev Nutr Diet 1988; 57: 214-74.
• 2 Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease?. Am J Clin Nutr 1997; 66 (suppl): 1020S-31S.
• 3 Geusens P, Wouters C, Nijs J, Jiang YB, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis – a 12-month double-blind, controlled study. Arthritis Rheum 1994; 37: 824-9.
• 4 Knapp HR. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 1997; 65 (suppl): 1687S-98S.
• 5 Malle E, Kostner GM. Effects of fish oils on lipid variables and platelet function indices. Prostag Leukotr Ess Fatty Ac 1993; 49: 645-63.
• 6 Li X, Steiner M. Fish oil: a potent inhibitor of platelet adhesiveness. Blood 1990; 76: 938-45.
• 7 Li X, Steiner M. Dose response of dietary fish oil supplementations on platelet adhesion. Arterioscler Thromb 1991; 11: 39-46.
• 8 Owens MR, Cave Jr WT. Dietary fish lipids do not diminish platelet adhesion to subendothelium. Br J Haematol 1990; 75: 82-5.
• 9 Kromhout D, Bosschieter EB, Coulander D. Inverse relationship between fish consumption and 20 year mortality from coronary heart disease. N Engl J Med 1985; 312: 1205-9.
• 10 Endres S, De Caterina R, Schmidt EB, Kristensen DS. n-3 polyunsaturated fatty acids: update 1995. Eur J Clin Invest 1995; 25: 629-38.
• 11 Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991; 54: 438-63.
• 12 Boudreau MD, Chanmugam PS, Hart SB, Lee SH, Hwang DH. Lack of dose response by dietary n-3 fatty acids at a costant ratio of n-3 to n-6 fatty acids in suppressing eicosanoid biosynthesis from arachidonic acid. Am J Clin Nutr 1991; 54: 111-7.
• 13 Bellavite P, Andrioli G, Guzzo P, Arigliano P, Chirumbolo S, Manzato F, Santonastaso C. A colorimetric method for the measurement of platelet adhesion in microtiter plates. Anal Biochem 1994; 216: 444-50.
• 14 Girelli D, Azzini M, Olivieri O, Guarini P, Trevisan MT, Lupo A, Bernich P, Panzetta G, Corrocher R. Red blood cells and platelet membrane fatty acids in non-dialyzed uremics. Clin Chim Acta 1992; 211: 155-66.
• 15 Lepage G, Roy CC. Direct transesterification of all classes of lipids in a one-step reaction. J Lipid Res 1986; 27: 114-20.
• 16 Vorster HH, Cummings JH, Veldman FJ. Diet and haemostasis: time for nutrition science to get more involved. Br J Nutr 1997; 77: 671-84.
• 17 Roth GJ. Platelets and blood vessels: the adhesion event. Immunol Today 1992; 13: 100-5.
• 18 Siess W. Molecular mechanisms of platelet activation. Physiol Rev 1989; 69: 58-178.
• 19 Minuz P, Andrioli G, Degan M, Gaino S, Ortolani R, Tommasoli R, Zuliani V, Lechi A, Lechi C. The F2-isoprostane 8-epiprostaglandin F2αincreases platelet adhesion and reduces the antiadhesive and antiaggregatory effects of NO. Arterioscler Thromb Vasc Biol 1998; 18: 1248-56.
• 20 Lechi C, Andrioli G, Gaino S, Tommasoli R, Zuliani V, Ortolani R, Degan M, Benoni G, Bellavite P, Lechi A, Minuz P. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid – an in vitro study of inhibition on the early phase of platelet activation and on TXA₂ production. Thromb Haemost 1996; 76: 791-8.
• 21 Andrioli G, Ortolani R, Fontana L, Gaino S, Bellavite P, Lechi C, Minuz P, Manzato F, Tridente G, Lechi A. Study of platelet adhesion in patients with uncomplicated hypertension. J Hyperten 1996; 14: 1215-21.
• 22 Schick PK. Megakaryocyte and platelet lipids. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Third Edition. Colman RW, Hirsh J, Marder VJ, Salzman EW. eds. Philadelphia, PA: JB Lippincott Company; 1994: 574-89.
• 23 Lands WEM, Culp BR, Hirai A, Gorman R. Relationship of thromboxane generation to the aggregation of platelets from humans: effects of eicosapentaenoic acid. Prostaglandins 1985; 30: 819-25.
• 24 Schmidt EB, Dyerberg J. Omega-3 fatty acids: current status in cardio-vascular medicine. Drugs 1994; 47: 405-24.
• 25 Andrioli G, Lussignoli S, Gaino S, Benoni G, Bellavite P. Study on paradoxical effects of NSAIDs on platelet adhesion. Inflammation 1997; 21: 519-30.